Rutgers researchers nearly swept the 2023 Philadelphia Nucleate Activator Program awards, highlighted by a team focusing on the creation of a new binge-eating disorder drug taking the High Performance Grand Prize.
Faculty Excellence
Internationally renowned Rutgers University scientist and former director of the Waksman Institute of Microbiology, Joachim Messing, was posthumously honored as this year’s recipient of the Science and Technology Medal from the Research & Development Council of New Jersey for his groundbreaking work in shotgun DNA sequencing.
Stories
Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.
The Rutgers research and innovation community came together to celebrate its own at the 2023 Patent Awards Celebration, in Trayes Hall at the Douglass Student Center.
Rutgers Office for Research is honoring Women’s History Month by highlighting researchers from each of the university’s four campuses: Rutgers Biomedical and Health Sciences (RBHS), Camden, Newark, and New Brunswick. These five women, and the impressive work they do every day to make the world a better place, represent the best of Rutgers; the diverse faculty and the variety of research conducted within, inclusive of STEM, arts, humanities and the social sciences.
To celebrate Black History Month, the Office for Research is highlighting some of the many researchers from across Rutgers, The State University of New Jersey who are making an impact on the university and their field of study. The vital work being conducted represents the diversity of research within Rutgers, which is inclusive of STEM, arts, humanities and the social sciences. The faculty members featured in this Q&A story are not just leaders in their fields; they also represent the notions of diversity, equity, and inclusion that the university and the Office for Research strive to uphold.
Rutgers Office for Research has signed an exclusive license with SoftGenetics, LLC for the company to commercialize innovative software technology developed by Rutgers-Camden professors Catherine Grgicak, PhD and Desmond Lun, PhD. The technology, called NOCIt, is a computational tool that calculates the probability of the number of contributors in a DNA profile.